| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $46,753,065 ) (Continued on the next page) |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | T32GM152775 | Critical Analysis of Data-Rich Networks for Biomedical Scientists in Training. | 001 | 2 | NIH | 4/25/2025 | $0 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | T32GM152775 | Critical Analysis of Data-Rich Networks for Biomedical Scientists in Training. | 000 | 2 | NIH | 1/15/2025 | $287,370 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | P50AA030407 | Alcohol Center Of Research -- Nebraska (ACORN) | 000 | 3 | NIH | 1/17/2025 | $1,588,725 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01DA060753 | Epigenetic regulation of astrocyte-specific NLRP6 inflammasome and PANoptosis in HIV Tat and methamphetamine-mediated neuroinflammation | 000 | 2 | NIH | 4/11/2025 | $509,793 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | UH3HL165740 | Behavioral Economic and Staffing Strategies To Increase Adoption of the ABCDEF Bundle in the ICU (BEST-ICU) | 000 | 3 | NIH | 3/27/2025 | $1,106,984 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | UH3HL165740 | Behavioral Economic and Staffing Strategies To Increase Adoption of the ABCDEF Bundle in the ICU (BEST-ICU) | 000 | 3 | NIH | 3/27/2025 | $200,000 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105-7835 | DOUGLAS | USA | D4054827 | Graduate Psychology Education Programs | 00 | 1 | HRSA | 6/12/2025 | $450,000 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA290859 | Lysosome Trapped FAP-Targeted Theranostics for Pancreatic Cancer | 001 | 2 | NIH | 5/22/2025 | $62,672 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA290859 | Lysosome Trapped FAP-Targeted Theranostics for Pancreatic Cancer | 000 | 2 | NIH | 2/17/2025 | $564,044 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01GM141232 | Regulation of SPRTN protease and SPRTN-mediated DNA-Protein Crosslink Repair | 000 | 4 | NIH | 3/25/2025 | $283,208 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | F32AA031180 | The role of alcohol-associated microbiota membrane vesicles in mucosal immunity | 001 | 3 | NIH | 6/6/2025 | $1,332 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | F32AA031180 | The role of alcohol-associated microbiota membrane vesicles in mucosal immunity | 000 | 3 | NIH | 5/14/2025 | $80,392 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01HL163288 | HEART Camp Connect: Promoting Adherence to Exercise in Adults with Heart Failure with Preserved Ejection Fraction | 001 | 3 | NIH | 6/4/2025 | $67,201 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01HL163288 | HEART Camp Connect: Promoting Adherence to Exercise in Adults with Heart Failure with Preserved Ejection Fraction | 000 | 3 | NIH | 4/25/2025 | $604,826 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01DK135817 | Development and Preclinical Evaluation of Nanoformulations in Liver Fibrotic Mice | 000 | 3 | NIH | 2/26/2025 | $365,775 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01AG077803 | MitoQ treatment of claudication: myofiber and micro-vessel pathology | 000 | 4 | NIH | 6/20/2025 | $566,185 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R00GM138920 | Genome-wide mechanisms and dynamics of ATP-dependent chromatin remodeling complexes | 000 | 5 | NIH | 3/31/2025 | $249,000 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01EB034202 | Polysaccharide putty formulations for tissue regeneration | 001 | 3 | NIH | 6/4/2025 | $361,640 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01EB034202 | Polysaccharide putty formulations for tissue regeneration | 003 | 3 | NIH | 6/17/2025 | $253,358 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01AI163042 | New generation of long acting nucleos(t)ides and immune stimulant for treatment of chronic hepatitis B | 000 | 4 | NIH | 4/7/2025 | $611,174 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | F99CA294241 | Tumor-cell intrinsic and extrinsic determinants of drug resistance and metastasis | 000 | 1 | NIH | 12/11/2024 | $3,000 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01NS128336 | Lipid nanomedicine targeting multiple signaling pathways of medulloblastoma | 000 | 4 | NIH | 5/21/2025 | $475,579 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01GM145647 | Deciphering the Enzymatic Mechanism of Superoxide Dismutase | 000 | 4 | NIH | 4/28/2025 | $431,383 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01GM145736 | Neuromuscular junction as a therapeutic target to improve post-traumatic outcomes | 000 | 4 | NIH | 3/25/2025 | $338,468 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R35GM144102 | Mechanisms of membrane trafficking in endocytic and non-endocytic pathways | 001 | 4 | NIH | 5/7/2025 | $546,437 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA263504 | Mechanisms underlying USP1-mediated bypass of EWS-FLI1 oncogene-induced replication stress in Ewing sarcoma | 000 | 4 | NIH | 6/26/2025 | $351,131 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | F30CA268766 | Molecular control of tumor-initiating cells in Ras-driven cancers | 000 | 3 | NIH | 6/17/2025 | $39,529 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R35GM150801 | Mechanisms of endosomal trafficking in lipid droplet catabolism | 000 | 3 | NIH | 4/30/2025 | $381,931 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01NS126089 | HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes | 000 | 5 | NIH | 6/13/2025 | $690,750 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA258621 | Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma | 001 | 5 | NIH | 5/22/2025 | $50,308 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA258621 | Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma | 000 | 5 | NIH | 3/27/2025 | $452,780 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA259168 | Development of an NTSR1-Targeted Radiotherapeutic for Colorectal Cancer | 001 | 5 | NIH | 5/28/2025 | $32,810 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA259168 | Development of an NTSR1-Targeted Radiotherapeutic for Colorectal Cancer | 000 | 5 | NIH | 3/14/2025 | $295,296 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA259080 | Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer | 001 | 4 | NIH | 5/22/2025 | $35,631 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA259080 | Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer | 000 | 4 | NIH | 2/13/2025 | $320,687 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01MH132517 | PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5 | 000 | 3 | NIH | 2/13/2025 | $587,137 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R03DA060076 | Impact of cannabidiol on HIV infection and methamphetamine abuse associated neuroinflammation | 000 | 2 | NIH | 3/17/2025 | $153,500 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R21AI180574 | Characterizing the Function of Cyclic di-AMP on Chlamydial Growth and Differentiation | 000 | 2 | NIH | 3/17/2025 | $186,119 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01DK131990 | Gut bacterial metallophores in the development and severity of inflammatory bowel disease | 001 | 4 | NIH | 6/11/2025 | $65,323 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01DK131990 | Gut bacterial metallophores in the development and severity of inflammatory bowel disease | 000 | 4 | NIH | 3/5/2025 | $587,908 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01AI169788 | T cell-innate immune crosstalk regulates Staphylococcus aureus craniotomy infection | 000 | 4 | NIH | 3/6/2025 | $563,390 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105-7835 | DOUGLAS | USA | M0131368 | Behavioral Health Workforce Education and Training (BHWET) Program | 00 | 9 | HRSA | 6/20/2025 | $600,000 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA255618 | Use of radioprotector in rectal cancer | 001 | 4 | NIH | 5/22/2025 | $60,394 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA255618 | Use of radioprotector in rectal cancer | 000 | 4 | NIH | 2/14/2025 | $543,557 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01HL163043 | Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury | 002 | 4 | NIH | 2/21/2025 | $416,745 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R35ES031708 | Aberrant DNA Repair and Lupus | 002 | 6 | NIH | 4/14/2025 | $789,292 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA281044 | Fidelity Mechanisms of DNA Polymerase Beta | 001 | 2 | NIH | 5/22/2025 | $62,041 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA281044 | Fidelity Mechanisms of DNA Polymerase Beta | 000 | 2 | NIH | 3/3/2025 | $558,374 |
| 2025 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198-7835 | DOUGLAS | USA | R01GM144414 | Insight into the mechanism of action of the SSB interactome | 000 | 4 | NIH | 1/27/2025 | $281,202 |
|